Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
22.07.2025 14:36:10
|
Quest Diagnostics Q2 Profit Climbs
(RTTNews) - Quest Diagnostics (DGX) released earnings for its second quarter that Increases, from the same period last year
The company's bottom line came in at $282 million, or $2.47 per share. This compares with $229 million, or $2.03 per share, last year.
Excluding items, Quest Diagnostics reported adjusted earnings of $298 million or $2.62 per share for the period.
The company's revenue for the period rose 15.2% to $2.761 billion from $2.397 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings: $282 Mln. vs. $229 Mln. last year. -EPS: $2.47 vs. $2.03 last year. -Revenue: $2.761 Bln vs. $2.397 Bln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 156,25 | 1,03% |
|